<DOC>
	<DOCNO>NCT00953303</DOCNO>
	<brief_summary>Evidence show glucocorticoid could induce potent diuretic action improve renal function patient decompensated congestive heart failure . Thus design study determine efficacy glucocorticoid cardiovascular mortality 30 day follow randomization .</brief_summary>
	<brief_title>The Effects Glucocorticoids Mortality Renal Function Patients With Acute Decompensated Heart Failure</brief_title>
	<detailed_description>Newly emerge clinical evidence show glucocorticoid , add best conventional therapy , could produce potent diuretic effect , improve renal function patient decompensated congestive heart failure . It hold ture even patient fail respond high dose furosemide ( &gt; 200mg/day ) . The present study confirm clinical efficacy glucocorticoid cardiovascular mortality patient decompensated congestive heart failure best conventional therapy .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Patients dyspnea rest due acutely decompensated CHF require hospitalization intravenous therapy . The cardiac etiology acutely decompensated CHF establish echocardiogram and/or chest xray film 2 following : 1 . &gt; 2pillow orthopnea study entry 2 . Jugular venous distention and/or abdominal discomfort due mesenteric congestion . Patients may acute decompensation chronic heart failure , gradual worsening chronic heart failure , new onset acutely decompensated CHF . Patients receive intravenous therapy i.e . Inotropic and/or vasodilator otherwise meet entry criterion also permit study . Patients sign cardiac shock also permit study . Patient refusal Any sign infection condition would contraindicate glucocorticoid use Poor control hypertension Poor control diabetes mellitus Active myocarditis Malignancy terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>heart failure</keyword>
	<keyword>prednisone</keyword>
	<keyword>cardiovascular mortality</keyword>
	<keyword>renal function</keyword>
</DOC>